Stock Events

Stock Events

Cytosorbents 

0
20
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

29OctExpected
Q2 2026
Next
-0.87
-0.84
-0.81
-0.78
Expected EPS
-0.77634
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HQE.F. It's not an investment recommendation.
Rigetti Computing
6
RGTI
Teucrium Wheat Fund
5
WEAT
Realty Income
4
O
NVIDIA
4
NVDA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Baxter International
BAX
Mkt Cap12.3B
Baxter International offers a range of dialysis products and acute therapies, directly competing with Cytosorbents' blood purification solutions.
Medtronic
MDT
Mkt Cap116.35B
Medtronic offers products for dialysis and blood management, competing in the broader market of medical devices for critical care, similar to Cytosorbents.
Danaher
DHR
Mkt Cap140.7B
Danaher Corporation, through its subsidiary Cytiva, provides products and services for life sciences research, competing in the bioprocessing space with Cytosorbents.
Boston Scientific
BSX
Mkt Cap62.29B
Boston Scientific Corporation competes in the medical devices sector, offering products that could be used in similar clinical settings as Cytosorbents' therapies.
Stryker
SYK
Mkt Cap105.7B
Stryker Corporation manufactures medical devices and equipment, including products for intensive care, which could be seen as complementary or competitive to Cytosorbents' offerings.
Abbott Laboratories
ABT
Mkt Cap176.41B
Abbott Laboratories offers a wide range of medical devices, diagnostics, and nutritional products, competing in the broader healthcare and medical device market.
Johnson & Johnson
JNJ
Mkt Cap640.02B
Johnson & Johnson, through its medical devices segment, competes across various healthcare sectors, including areas relevant to Cytosorbents' market.
Edwards Lifesciences
EW
Mkt Cap48.63B
Edwards Lifesciences specializes in heart valves and hemodynamic monitoring, competing in the critical care space where Cytosorbents operates.
SeaStar Medical Common Stock
ICU
Mkt Cap13.35M
ICU Medical provides infusion therapy and critical care products, competing in the market for medical devices and technologies for critical patient care.

About

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.
Show more...
CEO
Employees
129
Country
United States
ISIN
US23283X3052
WKN
000A42KBG

Listings

STU
DE
HQE1.STU
BOATS
BOATS
CTSO.BOATS
MU
DE
HQE1.MU
F
DE
HQE.F

0 Comments

Share your thoughts

FAQ

What is Cytosorbents stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Frankfurt Exchange exchange Cytosorbents stocks are traded under the ticker HQE.F.
When is the next Cytosorbents earnings date?▼
Cytosorbents is going to release the next earnings report on October 29, 2026.
What were Cytosorbents earnings last quarter?▼
HQE.F earnings for the last quarter are -0.87 EUR per share, whereas the estimation was -0.78 EUR resulting in a -11.11% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Cytosorbents have?▼
As of September 14, 2026, the company has 129 employees.
In which sector is Cytosorbents located?▼
Cytosorbents operates in the Other sector.
When did Cytosorbents complete a stock split?▼
Cytosorbents has not had any recent stock splits.
Where is Cytosorbents headquartered?▼
Cytosorbents is headquartered in PRINCETON, United States.